Tigliane diterpenes have been viewed as promising leads in a myriad of different medicinal applications ranging from immunomodulatory^[@R9]^ to anti-viral^[@R10]^ to anti-cancer.^[@R11]^ The most progressed compound in this class of natural products is phorbol 12-myristate 13-acetate (PMA), which is currently in phase II clinical trials for treatment of acute myeloid leukemia (AML).^[@R11]^ Remarkably, subtle perturbations of their structures can have a dramatic effect on their biological profiles, perhaps as a result of differing protein kinase C (PKC) subtype selectivity.^[@R9],[@R10]^ As such, phorbol esters and related terpenes have been a hotly pursued area of natural products research.^[@R1]^ Our interest in this family stemmed from the anti-cancer effects of certain phorbol analogs whose access was limited. In 2009, our lab described a fundamentally new strategy for the chemical synthesis of complex terpenes following the underlying logic of biosynthesis and demonstrated its utility by concisely accessing numerous eudesmane family members.^[@R2]^ This strategy has been successfully applied to germacrenes,^[@R3]^ complex taxanes,^[@R4],[@R5]^ and most recently ingenanes.^[@R6]-[@R8]^ In particular, the two-phase synthesis of (--)-ingenol (**2**) is only 14 steps from (+)-3-carene (**6**) and has enabled access to a variety of analogs that were not accessible by any other means.^[@R6]-[@R8]^ Since ingenanes (**4**) and tiglianes (**3**) are intimately related in nature it was hypothesized that intermediate **5**, available in \>100 gram quantities from LEO Pharma, might serve as an ideal starting point for a short route to **1**. The execution of this plan hinged on the invention of a simple solution to the challenge of incorporating the C-12 and C-13 oxygen atoms of **1**. Indeed, the difficulty in installing this functionality is notorious in the field. To date, only two total syntheses from the Wender group^[@R12]-[@R14]^ and two formal syntheses (one from the Wender^[@R15]^ and one from the Cha group^[@R16]^) of **1** have been reported in 40-52 steps (see [Supplementary Information for summary](#SD1){ref-type="supplementary-material"}).^[@R12]-[@R16]^ In these landmark studies, an α-oxygenated enone was prepared from a ketone and subsequently cyclopropanated to build in the C-13 oxidation *via* a six-step sequence. In addition, many elegant efforts towards **1** have been reported by the Shibasaki,^[@R17],[@R18]^ Wilson, Rigby, Harwood, Little, Page, Dauben, McMills, Paquette, Singh, Ovaska, West, Evans, and Li groups (for a listing of the 36 papers in this area, see [Supplementary Information](#SD1){ref-type="supplementary-material"}). The Shibasaki route is particularly instructive and illustrates the inherent challenge of using (+)-3-carene (**6**) as a starting material to (+)-phorbol (**1**) since 38 steps were required to reach a phorbol analog lacking the C-11 methyl and C-13 oxygen from **6**.^[@R17],[@R18]^ For the purposes of contextualizing the current studies, we define a reaction step as one in which a substrate is converted to a product in a single reaction flask (irrespective of the number of transformations) without intermediate workup or purification. Outlined below are studies that culminated in a two-phase, 19-step synthesis of **1** that solves these problems in an unusually concise and unique way.

The synthesis commenced with intermediate **5** ([Figure 2](#F2){ref-type="fig"}), provided by LEO Pharma in large quantities using our previously described route.^[@R6]^ Installation of the C-4 oxygen was accomplished using a Mukaiyama hydration and *in situ* silyl group installation to furnish **7** in 70% yield (gram scale). At this juncture, installation of the C-12 oxygen atom was pursued, requiring the selective oxidation of a methylene position in the presence of an enone, six tertiary C--H bonds, and two other competing methylene sites. In order to choose the proper oxidant for this bold transformation the structure was analyzed computationally ([Figure 3a](#F3){ref-type="fig"}) and by inference of innate reactivity using NMR ([Figure 3b](#F3){ref-type="fig"}). Thus, the pseudo-equatorial C--H bond at C-12 was predicted to be the most reactive based on the following considerations:^[@R19]^ (1) steric shielding of the C-6, C-7, C-8, and C-11 positions would decrease their rate of oxidation; (2) the higher s-character of the tertiary cyclopropane C--H bonds (C-13/14) makes them notoriously difficult to oxidize; (3) of the remaining carbon centers, ^[@R13]^C NMR indicated that C-12 is the most "nucleophilic"; (4) hyperconjugation from the π-like cyclopropane system should facilitate oxidation of the pseudo-equatorial C--H bond on C-12, and finally (5) strain-release may, to a small extent, accelerate such an oxidation.^[@R20]^ The small, reactive, electrophilic oxidant methyl(trifluoromethyl)dioxirane (TFDO) was therefore chosen due to its straightforward preparation and success in other challenging methylene oxidations.^[@R21]^ As predicted, TFDO cleanly achieved C--H oxidation at C-12 to deliver the intermediate cyclopropyl carbinol intermediate **8** (single diastereomer) which could be isolated and fully characterized on a gram scale. In practice, however, it was directly treated in the same flask with MgI~2~/ZnI~2~ to elicit a dehydrative ring opening^[@R22]^ to furnish diene **9** along with unreacted enone **7**. The anticipated tertiary iodide product was not observed presumably due to rapid elimination to form a diene system. The mixture of **7** and **9** was directly subjected to another Mukaiyama hydration to furnish the tertiary carbinol **10** in 34% isolated yield from **7** along with 62% recovered **7**. The addition of PPh~3~ to this type of reaction has not been reported before and was found to be essential to prevent the reactive intermediate peroxide adduct from generating an unwanted byproduct (see [Supplementary Information for details](#SD1){ref-type="supplementary-material"}).

With the cyclopropane ruptured, the stage was now set to install the C-12/13 oxygenation pattern along with reclosure of the cyclopropane. Overall, this was a maneuver without precedent that needed to be accomplished in a scalable and short fashion. Towards this end, chemoselective oxidation of the C-12/13 olefin to diketone **11** took place in near quantitative yield using Ru/NaBrO~3~. In order to reform the *gem*-dimethylcyclopropane moiety and access the correct oxidation state, a two-electron reduction of the diketone to an enediol would need to take place followed by intramolecular cyclization. Whereas attempts at acetylation of the hindered tertiary alcohol were fruitless and mesylation led to rapid elimination (as with the putative iodide intermediate in **8** → **9**), treatment with trifluoroacetic anhydride smoothly led to an intermediate trifluoroacetate. This ester could be treated in the same flask with Zn to deliver an intermediate (**12**) that was difficult to assign without the aid of X-ray crystallography. Although the desired reduction took place, it was accompanied by the formation of an additional, unwanted, and bizarre C--C bond between C-13 and the carbonyl group of the trifluoroester. Although aldol additions of enediols to aldehydes^[@R23]^ and ketones^[@R24]^ are known, there is no precedent for such reactivity with esters. It was reasoned that this product originated from a highly reactive enediol intermediate (such as **A**; R = H) that might be regenerated under equilibrating conditions. In support of this hypothesis was the empirical observation that conversion of **11** to **12** initially resulted in the formation of a *ca*. 1:1 mixture of **12** along with an isomeric species tentatively assigned as the diastereomeric aldol adduct. Over 24 hours this mixture equilibrated to **12** exclusively perhaps due to stabilizing intramolecular hydrogen bonding interactions. Conditions were thus evaluated to coax the enediol back into existence (retro aldol) with the hope that concomitant irreversible cyclopropane formation (*via* attack at C-15) would take place. However, treatment of **12** with catalytic Sc(OTf)~3~ in DMF led instead to the cyclobutanone **13**. Although clearly undesired, this was encouraging since **13** must have been derived from the desired hydroxy-cyclopropane **B** *via* a 1,2-shift which in turn was produced *via* the enediol intermediate **A** (R = H). Indeed, the formation of cyclobutanones such as **13** from hydroxycyclopropanes is precedented.^[@R25]^ In order to circumvent this undesired pathway, intermediate **12** was converted to hemiorthoester **14** by simple treatment with Ac~2~O followed by exposure to Et~3~N and gentle heating to 60 °C to deliver **15**. The remarkable single flask conversion of **11** to **15** can be conducted on a gram scale and presumably succeeds due to the *in situ* formation of intermediate **A** (R = Ac). The conversion of **A** to the desired cyclopropane is believed to be concerted since no elimination products were observed (*vide supra*). This reaction cascade consists of thirteen discreet events occuring in the same flask, forming two new C--C bonds, three new ring systems, and three C--O bonds along with the cleavage of one C--C bond, two ring systems, and two C--O bonds. It unravels a complex polycyclic network to a kinetic endpoint using simple reagents thereby solving the most daunting challenge posed by **1**.

The final eight steps of the synthesis served to install two additional oxygen atoms, one methyl group, and the proper C-12 and C-10 stereochemistry. Attempts to install the key C-10 stereocenter by way of conjugate reduction were met with failure despite extensive experimentation (see [Supplementary Information for details](#SD1){ref-type="supplementary-material"}). Thus, allylic transposition of **15,** the Achilles heel of the synthesis from an efficiency standpoint, employed TsNHNH~2~ under reductive conditions leading to **16** in 40%. Allylic oxidation with CrO~3~,^[@R26]^ delivered enone **17** in 46% yield. A two-step methyl group introduction was accomplished by formation of an α-iodoenone (TMSN~3~, I~2~)^[@R27]^ followed by a Stille coupling^[@R28]^ affording **18** in 64% overall yield along with 33% recovered **17**. Selective removal of the C-7 and C-9 silyl groups with HF·pyridine complex led to a diol that could be selectively dehydrated using Martin Sulfurane reagent to an unstable olefin that was directly oxidized using SeO~2~ to aldehyde **19** in 51% overall yield. The selective cleavage of the C-7 and C-9 silyl groups may stem from the inductive effect of the C-3 carbonyl group, which could make C-4 silyl group less reactive to acids. X-ray crystallographic analysis of **19** confirmed the structural assignments made thus far. To complete the synthesis, **19** was reduced to the allylic alcohol and shielded as the acetate ester. Attempts to directly reduce the C-20 aldehyde and the C-12 ketone in **19** were thwarted by the rapid rate of the C-3 enone carbonyl reduction in the presence of the C-20 free primary alcohol (the C-20 hydroxy group is actually proximate to C-3 as judged by molecular models). Stereoselective ketone reduction using NaBH(OAc)~3~ followed by successive treatment with fluoride and hydroxide sources (TBAF and Ba(OH)~2~ respectively) led to optically pure (+)-**1** (synthetic, \[α\]^[@R26]^ ~D~ 105.37 (*c* 0.23, CH~3~OH); natural, \[α\]^[@R27]^ ~D~ 104.25 (*c* 0.20, CH~3~OH)) in 72% isolated yield (15 mg prepared by this route).

The concise route to **1** is enabled by a fundamentally different retrosynthetic approach to terpene synthesis in the laboratory rather than focusing on the invention of a new synthetic method. Indeed, the newest method employed in this synthesis is a Stille coupling, invented in the 1980\'s.^[@R28]^ Although the development of new synthetic methodologies are of paramount importance to push the field of organic chemistry forward, this work emphasizes the equally important role of strategy design in complex natural product total synthesis.^[@R29]^ By holistically mimicking the biosynthesis of ingenol (**2**) in the laboratory,^[@R6],[@R7]^ the interrelationship between ingenanes and tiglianes could be leveraged using the same building block for both synthetic routes. Since two-phase terpene synthesis builds the carbon skeleton with a strategically planned redox state, the majority of steps can focus on installing key oxidations rather than repositioning functional groups and C--C bonds. Indeed, access to phorbol (**1**) only requires five additional steps compared to ingenol (**2**) due to the presence of two additional oxygen atoms (C-12/13) placed at particularly challenging locations on the carbon skeleton. Successful installation of these oxygenations and two others directly or indirectly relied on the application of C--H functionalization logic to pinpoint both the location and choreography of reactions.^[@R19],[@R30]^ This artificial oxidase phase will enable the synthesis of analogs containing deep-seated modifications in the same fashion that has recently been reported for ingenol (**2**).^[@R8]^ Although the route, in its current concise form, cannot compete with isolation for the procurement of large quantities of phorbol (**1)**, it can be argued that it *could* be adapted to become truly scalable if the need arose. Rather, the purpose of this synthesis is to enable rapid access to new tigliane family members with exciting bioactivity that are either difficult or impossible to access through isolation or semisynthesis.
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![A two-phase approach to ingenanes and tiglianes enables a concise approach to the legendary phorbol structure](nihms753652f1){#F1}

![19-step total synthesis of **1**. Reagents and conditions: **7.** Mn(acac)~2~, PhSiH~3~, O~2~, EtOH, then TMSOTf, Et~3~N, CH~2~Cl~2~, 0 °C, 70%. **8.** TFDO, CH~2~Cl~2~, 0 °C, then ZnI~2~, MgI~2~, Et~2~O. **9.** Mn(acac)~2~, PhSiH~3~, O~2~, PPh~3~, EtOH, 2 steps (34% **10** + 62% **7**). **10.** RuCl~3~, NaBrO~3~, NaHCO~3~, EtOAc, CH~3~CN, H~2~O, 96%. **11.** TFAA, DMAP, CH~2~Cl~2~, 0 °C, then Zn, AcOH, CH~2~Cl~2~, then Ac~2~O, DMAP, CH~2~Cl~2~, 0 °C, then Et~3~N, DMF, 60 °C, 64%. **12.** TsNHNH~2~, MeOH, reflux, then NaBH~3~CN, AcOH, reflux, 40%. **13.** CrO~3~, 3,5-DMP, CH~2~Cl~2~, 0 °C to rt, 46%. **14.** TMSN~3~, DCE, 70 °C, then I~2~, DCE, pyridine, 70 °C. **15.** Me~4~Sn, PdCl~2~(PhCN)~2~, AsPh~3~, CuI, NMP, 80 °C, 2 steps (64% **18** + 33% **17**). **16.** HF·Pyridine, THF, 0 °C. **17.** Martin Sulfurane, DCE, 60 °C, then SeO~2~, benzene, 80 °C, 2 steps 51%. **18.** NaBH~4~, MeOH, -40 °C, then Ac~2~O, DMAP, CH~2~Cl~2~, 93%. **19.** NaBH(OAc)~3~, benzene, reflux, then TBAF, THF, 0 °C, then Ba(OH)~2~, MeOH, 72%.](nihms753652f2){#F2}

![(a) Structural analysis of intermediate **7** calculated using MacroModel 10.8 (Schrödinger LLC) (b) ^[@R13]^C NMR can be used to predict the most nucleophilic methylene C--H bond after taking into account the role of other factors (see text)](nihms753652f3){#F3}
